This article is a collaboration between 鶹ý and:
What are the key points from the recent spate of positive trials for mechanical thrombectomy for certain large-vessel ischemic strokes? , explores the significance of MR CLEAN, SWIFT-PRIME, and other randomized trials.
Lyden serves as chair of the department of neurology and director of the stroke program at Cedars-Sinai Medical Center in Los Angeles. He was an investigator on the key in the mid-1990s and remains on the editorial boards of Stroke, the International Journal of Stroke, and the Journal of Stroke and Cerebrovascular Disease.
From the American Heart Association: